Brenda M Sandmaier

Brenda M Sandmaier

UNVERIFIED PROFILE

Are you Brenda M Sandmaier?   Register this Author

Register author
Brenda M Sandmaier

Brenda M Sandmaier

Publications by authors named "Brenda M Sandmaier"

Are you Brenda M Sandmaier?   Register this Author

100Publications

2930Reads

32Profile Views

Allogeneic Hematopoietic Cell Transplantation in the Outpatient Setting.

Biol Blood Marrow Transplant 2019 Nov 28;25(11):2152-2159. Epub 2019 Jun 28.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.06.025DOI Listing
November 2019

Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk Lymphoma.

Clin Cancer Res 2019 Sep 3. Epub 2019 Sep 3.

Department of Medicine, University of Washington School of Medicine, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-1567DOI Listing
September 2019

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.

Haematologica 2019 09 26. Epub 2019 Sep 26.

Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2019.220756DOI Listing
September 2019

EASIX and mortality after allogeneic stem cell transplantation.

Bone Marrow Transplant 2019 Sep 26. Epub 2019 Sep 26.

Charité Universitätsmedizin Berlin, Hematology, Oncology and Tumorimmunology, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0703-1DOI Listing
September 2019

Second allogeneic hematopoietic cell transplantation for relapse after first allografts.

Leuk Lymphoma 2019 Jul 22;60(7):1758-1766. Epub 2019 Jan 22.

c Clinical Research Division , Fred Hutchinson Cancer Research Center , Seattle , WA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1542149DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594865PMC
July 2019

Low-Dose Azacitidine with DNMT1 Level Monitoring to Treat Post-Transplantation Acute Myelogenous Leukemia or Myelodysplastic Syndrome Relapse.

Biol Blood Marrow Transplant 2019 Jun 30;25(6):1122-1127. Epub 2018 Dec 30.

University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, Ohio; Case Comprehensive Cancer Center, Cleveland, Ohio. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183169
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.12.764DOI Listing
June 2019

Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources.

Biol Blood Marrow Transplant 2019 05 28;25(5):1045-1052. Epub 2018 Nov 28.

Clinical Research Division, Fred Hutchinson Cancer Research Center; Seattle, Washington; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine; Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.11.030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511303PMC
May 2019

Long-Term Follow-Up of Y-Ibritumomab Tiuxetan, Fludarabine, and Total Body Irradiation-Based Nonmyeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B Cell Lymphoma.

Biol Blood Marrow Transplant 2018 11 3;24(11):2211-2215. Epub 2018 Jul 3.

Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183038
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.06.033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251312PMC
November 2018

Inosine Monophosphate Dehydrogenase Pharmacogenetics in Hematopoietic Cell Transplantation Patients.

Biol Blood Marrow Transplant 2018 09 12;24(9):1802-1807. Epub 2018 Apr 12.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.04.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414227PMC
September 2018

Description and prognostic significance of the kinetics of minimal residual disease status in adults with acute lymphoblastic leukemia treated with HyperCVAD.

Am J Hematol 2018 08 27;93(4):546-552. Epub 2018 Jan 27.

Department of Medicine, University of Washington School of Medicine, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25030DOI Listing
August 2018

Reversal of Low Donor Chimerism after Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion: A Prospective Phase II Multicenter Trial.

Biol Blood Marrow Transplant 2018 02 12;24(2):308-313. Epub 2017 Oct 12.

Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.10.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767527PMC
February 2018

Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.

Biol Blood Marrow Transplant 2017 Oct 7;23(10):1669-1677. Epub 2017 Jun 7.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington; Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Hematology-Oncology, Seattle Children's Hospital, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.06.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605451PMC
October 2017

Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-Cell acute lymphoblastic leukemia.

Cancer 2017 Sep 27;123(17):3346-3355. Epub 2017 Apr 27.

Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30737DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568918PMC
September 2017

Hematopoietic Cell Transplantation in Myelodysplastic Syndromes after Treatment with Hypomethylating Agents.

Biol Blood Marrow Transplant 2017 Sep 30;23(9):1509-1514. Epub 2017 Jun 30.

Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA; Medical Oncology, University of Washington Medical Center/Seattle Cancer Care Alliance, Seattle, WA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.05.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481669PMC
September 2017

EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis.

Lancet Haematol 2017 Sep 18;4(9):e414-e423. Epub 2017 Jul 18.

Charité University Medicine Berlin, Haematology, Oncology and Tumorimmunology, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(17)30108-4DOI Listing
September 2017

Cord-Blood Transplantation in Patients with Minimal Residual Disease.

N Engl J Med 2016 Sep;375(10):944-53

From the Clinical Research Division, Fred Hutchinson Cancer Research Center (F.M., T.G., A.W., M.E.F., K.D., R.W., M.M., J.H.D., M.S., A.D., B.M.S., R.S., E.P., F.R.A., C.D.), and the Departments of Medicine (F.M., B.W., M.E.F., M.M., J.H.D., M.S., B.M.S., R.S., E.P., F.R.A.) and Pediatrics (A.W., A.D., C.D.), University of Washington - both in Seattle.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1602074DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513721PMC
September 2016

Association of Distance from Transplantation Center and Place of Residence on Outcomes after Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2016 07 22;22(7):1319-1323. Epub 2016 Mar 22.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.03.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905774PMC
July 2016

Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic Syndrome.

Biol Blood Marrow Transplant 2016 07 6;22(7):1227-1233. Epub 2016 Apr 6.

Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Washington Medical Center/Seattle Cancer Care Alliance, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.03.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999078PMC
July 2016

Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute Leukemia.

Biol Blood Marrow Transplant 2016 06 21;22(6):1024-1029. Epub 2016 Feb 21.

Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.02.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867266PMC
June 2016

Steroids Versus Steroids Plus Additional Agent in Frontline Treatment of Acute Graft-versus-Host Disease: A Systematic Review and Meta-Analysis of Randomized Trials.

Biol Blood Marrow Transplant 2016 06 10;22(6):1133-1137. Epub 2016 Mar 10.

The Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045896PMC
http://dx.doi.org/10.1016/j.bbmt.2016.02.021DOI Listing
June 2016

Nonmyeloablative allogeneic hematopoietic cell transplantation.

Haematologica 2016 05;101(5):521-30

Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.132860DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004381PMC
May 2016

Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study.

Lancet Haematol 2016 Mar 20;3(3):e119-27. Epub 2016 Feb 20.

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(15)00289-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914379PMC
March 2016

Anti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftment.

Blood 2016 Jan 17;127(3):352-9. Epub 2015 Nov 17.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-12-617019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722286PMC
January 2016

α-Imaging Confirmed Efficient Targeting of CD45-Positive Cells After 211At-Radioimmunotherapy for Hematopoietic Cell Transplantation.

J Nucl Med 2015 Nov 3;56(11):1766-73. Epub 2015 Sep 3.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington Department of Medicine, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.162388DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675464PMC
November 2015

Design and Validation of an Augmented Hematopoietic Cell Transplantation-Comorbidity Index Comprising Pretransplant Ferritin, Albumin, and Platelet Count for Prediction of Outcomes after Allogeneic Transplantation.

Biol Blood Marrow Transplant 2015 Aug 7;21(8):1418-24. Epub 2015 Apr 7.

Transplantation Biology Program, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791150023
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2015.04.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506728PMC
August 2015

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Authors:
Ayalew Tefferi Hagop Kantarjian S Vincent Rajkumar Lawrence H Baker Jan L Abkowitz John W Adamson Ranjana Hira Advani James Allison Karen H Antman Robert C Bast John M Bennett Edward J Benz Nancy Berliner Joseph Bertino Ravi Bhatia Smita Bhatia Deepa Bhojwani Charles D Blanke Clara D Bloomfield Linda Bosserman Hal E Broxmeyer John C Byrd Fernando Cabanillas George Peter Canellos Bruce A Chabner Asher Chanan-Khan Bruce Cheson Bayard Clarkson Susan L Cohn Gerardo Colon-Otero Jorge Cortes Steven Coutre Massimo Cristofanilli Walter J Curran George Q Daley Daniel J DeAngelo H Joachim Deeg Lawrence H Einhorn Harry P Erba Francisco J Esteva Elihu Estey Isaiah J Fidler James Foran Stephen Forman Emil Freireich Charles Fuchs James N George Morie A Gertz Sergio Giralt Harvey Golomb Peter Greenberg Jordan Gutterman Robert I Handin Samuel Hellman Paulo Marcelo Hoff Ronald Hoffman Waun Ki Hong Mary Horowitz Gabriel N Hortobagyi Clifford Hudis Jean Pierre Issa Bruce Evan Johnson Philip W Kantoff Kenneth Kaushansky David Khayat Fadlo R Khuri Thomas J Kipps Margaret Kripke Robert A Kyle Richard A Larson Theodore S Lawrence Ross Levine Michael P Link Scott M Lippman Sagar Lonial Gary H Lyman Maurie Markman John Mendelsohn Neal J Meropol Yoav Messinger Therese M Mulvey Susan O'Brien Roman Perez-Soler Raphael Pollock Josef Prchal Oliver Press Jerald Radich Kanti Rai Saul A Rosenberg Jacob M Rowe Hope Rugo Carolyn D Runowicz Brenda M Sandmaier Alan Saven Andrew I Schafer Charles Schiffer Mikkael A Sekeres Richard T Silver Lillian L Siu David P Steensma F Marc Stewart Wendy Stock Richard Stone Rainer Storb Louise C Strong Martin S Tallman Michael Thompson Naoto T Ueno Richard A Van Etten Julie M Vose Peter H Wiernik Eric P Winer Anas Younes Andrew D Zelenetz Charles A LeMaistre

Mayo Clin Proc 2015 Aug 23;90(8):996-1000. Epub 2015 Jul 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2015.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365030PMC
August 2015

Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia.

Haematologica 2015 Jul 20;100(7):e254-6. Epub 2015 Mar 20.

Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.118570DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486235PMC
July 2015

Association of fludarabine pharmacokinetic/dynamic biomarkers with donor chimerism in nonmyeloablative HCT recipients.

Cancer Chemother Pharmacol 2015 Jul 17;76(1):85-96. Epub 2015 May 17.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2768-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489995PMC
July 2015

Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission.

Biol Blood Marrow Transplant 2015 Feb 30;21(2):373-8. Epub 2014 Sep 30.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.09.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297535PMC
February 2015

Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation.

Biol Blood Marrow Transplant 2015 Feb 1;21(2):281-7. Epub 2014 Nov 1.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.10.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408880PMC
February 2015

Impact of donor age on outcome after allogeneic hematopoietic cell transplantation.

Biol Blood Marrow Transplant 2015 Jan 30;21(1):105-12. Epub 2014 Sep 30.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Oncology, University of Washington, School of Medicine, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791140060
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2014.09.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286386PMC
January 2015

Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administration.

Cancer Chemother Pharmacol 2015 Jan 6;75(1):67-75. Epub 2014 Nov 6.

Department of Pharmacy, School of Pharmacy, University of Washington, Box 357630, Seattle, WA, 98195, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-014-2618-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282607PMC
January 2015

Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.

Biol Blood Marrow Transplant 2014 Nov 10;20(11):1767-71. Epub 2014 Jul 10.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.07.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346133PMC
November 2014

Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantation.

Biol Blood Marrow Transplant 2014 Oct 9;20(10):1544-52. Epub 2014 Jun 9.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; School of Pharmacy, University of Washington, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.05.032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163086PMC
October 2014

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation.

J Clin Oncol 2014 Oct 25;32(29):3249-56. Epub 2014 Aug 25.

Mohamed L. Sorror, Rainer F. Storb, Brenda M. Sandmaier, Fabiana Ostronoff, H. Joachim Deeg, Karen L. Syrjala, Elihu Estey, David G. Maloney, Frederick R. Appelbaum, Paul J. Martin, and Barry E. Storer, Fred Hutchinson Cancer Research Center; Mohamed L. Sorror, Rainer F. Storb, Brenda M. Sandmaier, Fabiana Ostronoff, H. Joachim Deeg, Karen L. Syrjala, Elihu Estey, David G. Maloney, Frederick R. Appelbaum, and Paul J. Martin, University of Washington School of Medicine; Barry E. Storer, University of Washington School of Public Health, Seattle, WA; Smita Bhatia, City of Hope School of Medicine, Duarte, CA; Richard T. Maziarz, Center for Hematologic Malignancies, Oregon Health & Science University Knight Cancer Institute and School of Medicine, Portland, OR; Michael A. Pulsipher, University of Utah School of Medicine and Primary Children's Medical Center, Huntsman Cancer Institute, Salt Lake City, UT; and Michael B. Maris, Colorado Blood Cancer Institute School of Medicine, Denver, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.8157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178523PMC
October 2014

Pharmacokinetic and pharmacodynamic analysis of inosine monophosphate dehydrogenase activity in hematopoietic cell transplantation recipients treated with mycophenolate mofetil.

Biol Blood Marrow Transplant 2014 Aug 13;20(8):1121-9. Epub 2014 Apr 13.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; School of Pharmacy, University of Washington, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.03.032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099316PMC
August 2014

Failure-free survival after initial systemic treatment of chronic graft-versus-host disease.

Blood 2014 Aug 29;124(8):1363-71. Epub 2014 May 29.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; and Departments of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-03-563544DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141518PMC
August 2014

Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.

Blood 2014 Jul 5;124(2):287-95. Epub 2014 May 5.

Clinical Statistics Program, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; and Department of Biostatistics, University of Washington School of Public Health, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-01-550566DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093684PMC
July 2014

Conditioning regimens for hematopoietic cell transplantation: one size does not fit all.

Blood 2014 Jul 9;124(3):344-53. Epub 2014 Jun 9.

Fred Hutchinson Cancer Research Center, Seattle, WA; and University of Washington School of Medicine, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-02-514778DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102707PMC
July 2014

Costs of allogeneic hematopoietic cell transplantation using reduced intensity conditioning regimens.

Oncologist 2014 Jun 5;19(6):639-44. Epub 2014 May 5.

Division of Hematology/Oncology, Mayo Clinic in Arizona, Phoenix, Arizona, USA; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0406DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041670PMC
June 2014

Safety of treatment with DLA-identical or unrelated mesenchymal stromal cells in DLA-identical canine bone marrow transplantation.

Chimerism 2013 Jul-Sep;4(3):95-101. Epub 2013 May 29.

Clinical Research Division; Fred Hutchinson Cancer Research Center; Seattle, WA USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/chim.25110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782551PMC
April 2014

Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission.

J Clin Oncol 2013 Nov 23;31(31):3883-8. Epub 2013 Sep 23.

Raya Mawad, Ted A. Gooley, Vicky Sandhu, Bart Scott, Brenda M. Sandmaier, Paul O'Donnell, Pamela S. Becker, Stephen Petersdorf, Kathleen Shannon Dorcy, Paul Hendrie, Mohamed L. Sorror, Roland B. Walter, H. Joachim Deeg, Frederick R. Appelbaum, Elihu H. Estey, and John M. Pagel, Fred Hutchinson Cancer Research Center; Raya Mawad, Bart Scott, Brenda M. Sandmaier, Paul O'Donnell, Pamela S. Becker, Stephen Petersdorf, Paul Hendrie, Mohamed L. Sorror, Roland B. Walter, H. Joachim Deeg, Frederick R. Appelbaum, Elihu H. Estey, and John M. Pagel, University of Washington, Seattle, WA; and Jack Lionberger, St Louis University, St Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.50.2567DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805928PMC
November 2013

Allogeneic hematopoietic cell transplantation for indolent non-Hodgkin lymphoma: indications and outcomes.

Curr Opin Hematol 2013 Nov;20(6):509-14

Transplantation Biology Program, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0b013e328365a151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112741PMC
November 2013

A pilot pharmacologic biomarker study in HLA-haploidentical hematopoietic cell transplant recipients.

Cancer Chemother Pharmacol 2013 Sep 2;72(3):607-18. Epub 2013 Aug 2.

Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-013-2232-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786586PMC
September 2013

Nonrelapse mortality and mycophenolic acid exposure in nonmyeloablative hematopoietic cell transplantation.

Biol Blood Marrow Transplant 2013 Aug 6;19(8):1159-66. Epub 2013 May 6.

Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.04.026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720781PMC
August 2013

Costs of second allogeneic hematopoietic cell transplantation.

Transplantation 2013 Jul;96(1):108-15

Division of Hematology/Oncology, Mayo Clinic in Arizona, Phoenix, AZ, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0b013e318294caf1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696423PMC
July 2013

Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease.

Blood 2013 Mar 15;121(12):2340-6. Epub 2013 Jan 15.

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-11-465583DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606068PMC
March 2013

Conditioning with α-emitter based radioimmunotherapy in canine allogeneic hematopoietic cell transplantation.

Chimerism 2012 Apr-Jun;3(2):40-2. Epub 2012 Apr 1.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/chim.20726DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442811PMC
January 2013

Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation.

Biol Blood Marrow Transplant 2012 Nov 7;18(11):1687-99. Epub 2012 Jun 7.

Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division & Clinical Research Division, Seattle, Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.05.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467354PMC
November 2012